Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 332 followers
Latest posts
Last updated about 2 hours ago
European Medicines Agency (EMA) / European Chemicals Agency (ECHA) joint meeting with industry stakeholders, Online, European Medicines Agency, Amsterdam, the Netherlands, from 9 June 2026, 09:00 (CEST) to 9 June 2026, 12:00 (CEST)
about 4 hours ago
European Medicines Agency (EMA) / European Chemicals Agency (ECHA) joint meeting with...
Human medicines European public assessment report (EPAR): Calquence, acalabrutinib, Date of authorisation: 05/11/2020, Revision: 12, Status: Authorised
about 4 hours ago
Human medicines European public assessment report (EPAR): Calquence, acalabrutinib, Date of authorisation...
Human medicines European public assessment report (EPAR): Verzenios, abemaciclib, Date of authorisation: 26/09/2018, Revision: 19, Status: Authorised
about 4 hours ago
Human medicines European public assessment report (EPAR): Verzenios, abemaciclib, Date of authorisation...
Human medicines European public assessment report (EPAR): Qdenga, dengue tetravalent vaccine (live, attenuated), Date of authorisation: 05/12/2022, Revision: 7, Status: Authorised
about 4 hours ago
Human medicines European public assessment report (EPAR): Qdenga, dengue tetravalent vaccine (live...
Accelerating Clinical Trials in the EU (ACT EU)
about 4 hours ago
Accelerating Clinical Trials in the EU (ACT EU)
Human medicines European public assessment report (EPAR): Sunosi, solriamfetol, Date of authorisation: 16/01/2020, Revision: 11, Status: Authorised
about 5 hours ago
Human medicines European public assessment report (EPAR): Sunosi, solriamfetol, Date of authorisation...
Human medicines European public assessment report (EPAR): Opdualag, relatlimab,nivolumab, Date of authorisation: 15/09/2022, Revision: 8, Status: Authorised
about 5 hours ago
Human medicines European public assessment report (EPAR): Opdualag, relatlimab,nivolumab, Date of authorisation...
Timetable: Annual renewal application of conditional marketing authorisation
about 5 hours ago
Timetable: Annual renewal application of conditional marketing authorisation
Timetable: Annual renewal application of conditional marketing authorisation - ATMP
about 5 hours ago
Timetable: Annual renewal application of conditional marketing authorisation - ATMP